[PDF][PDF] Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6

…, BL Larson, L Semprun-Prieto, P Delafontaine… - Cell stem cell, 2009 - cell.com
Quantitative assays for human DNA and mRNA were used to examine the paradox that
intravenously (iv) infused human multipotent stromal cells (hMSCs) can enhance tissue repair …

[HTML][HTML] A pharmacogenetic versus a clinical algorithm for warfarin dosing

…, J Gujral, P Delafontaine… - … England Journal of …, 2013 - Mass Medical Soc
Background The clinical utility of genotype-guided (pharmacogenetically based) dosing of
warfarin has been tested only in small clinical trials or observational studies, with equivocal …

Expression, regulation, and function of IGF-1, IGF-1R, and IGF-1 binding proteins in blood vessels

P Delafontaine, YH Song, Y Li - Arteriosclerosis, thrombosis, and …, 2004 - Am Heart Assoc
The vascular insulin-like growth factor (IGF)-1 system includes the IGFs, the IGF-1 receptor (IGF-1R),
and multiple binding proteins. This growth factor system exerts multiple physiologic …

[HTML][HTML] Mechanisms of IGF-1-mediated regulation of skeletal muscle hypertrophy and atrophy

T Yoshida, P Delafontaine - Cells, 2020 - mdpi.com
Insulin-like growth factor-1 (IGF-1) is a key growth factor that regulates both anabolic and
catabolic pathways in skeletal muscle. IGF-1 increases skeletal muscle protein synthesis via …

IL-6 and serum amyloid A synergy mediates angiotensin II–induced muscle wasting

…, J Du, Z Hu, G Han, P Delafontaine… - Journal of the …, 2009 - journals.lww.com
Animal studies suggest that increased levels of circulating angiotensin II (AngII) could
contribute to the loss of lean body mass in chronic kidney disease, but the mechanism by which …

Sodium excretion and the risk of cardiovascular disease in patients with chronic kidney disease

…, W Yang, LJ Appel, JW Kusek, A Alper, P Delafontaine… - Jama, 2016 - jamanetwork.com
Importance Patients with chronic kidney disease (CKD) are at an increased risk of cardiovascular
disease (CVD) compared with the general population. Prior studies have produced …

Aging, atherosclerosis, and IGF-1

…, A Anwar, SY Shai, P Delafontaine - … Series A: Biomedical …, 2012 - academic.oup.com
Insulin-like growth factor 1 (IGF-1) is an endocrine and autocrine/paracrine growth factor that
circulates at high levels in the plasma and is expressed in most cell types. IGF-1 has major …

[HTML][HTML] Endoluminal beta-radiation therapy for the prevention of coronary restenosis after balloon angioplasty

…, J Kurtz, R Simon, P Delafontaine… - … England Journal of …, 2001 - Mass Medical Soc
Background Beta radiation is effective in reducing vascular neointimal proliferation in animals
after injury caused by balloon angioplasty. However, the lowest dose that can prevent …

Molecular mechanisms and signaling pathways of angiotensin II-induced muscle wasting: potential therapeutic targets for cardiac cachexia

…, Y Higashi, S Sukhanov, P Delafontaine - The international journal …, 2013 - Elsevier
Cachexia is a serious complication of many chronic diseases, such as congestive heart failure
(CHF) and chronic kidney disease (CKD). Many factors are involved in the development …

Nonsteroidal anti-inflammatory drugs and cardiovascular risk

PA Howard, P Delafontaine - Journal of the American College of …, 2004 - jacc.org
Nonsteroidal anti-inflammatory drugs (NSAID) inhibit cyclooxygenase (COX) enzymes, which
exist in at least two isoforms, COX-1 and COX-2. Aspirin and older agents in this class are …